PODESTA.COM for AIM IMMUNOTECH INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 19, 2023 | $60,000 | Replaced |
| 2nd Quarter - Amendment | Oct 20, 2023 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to cancer treatment and Cancer Moonshot Initiative Issues related to COVID therapies and NIH RECOVER Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH DEMAREE | — |
| HELEN HAGERTY New | — |
| ANTHONY PODESTA | — |
Budget/Appropriations BUD
Issues related to funding for clinical trials.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH DEMAREE New | — |
| HELEN HAGERTY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.